Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Baumert BG, Hegi ME, van den Bent MJ, von Deimling A, Gorlia T, Hoang-Xuan K, Brandes AA, Sargos P, Taphoorn MJB, Vauleon E, Philips C, Kros JM, Bady P, Wick W, Enting R, Reni M, Thiessen B, Dhermain F, Bromberg JE, Jacob J, Reijneveld JC, Chinot O, Gijtenbeek JMM, Rossiter JP, Balana C, Azevedo ALS, Clement PM, Berghoff A, Tzuk-Shina T, Weller M, Nordal RA, Rees J, Lacombe DA, Mason WP, Stupp R

Open source

DOI: 10.1200/jco-25-02735
Published: 2026 Jul 2
Container: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco-25-02735,
  title = {Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).},
  author = {Baumert BG and Hegi ME and van den Bent MJ and von Deimling A and Gorlia T and Hoang-Xuan K and Brandes AA and Sargos P and Taphoorn MJB and Vauleon E and Philips C and Kros JM and Bady P and Wick W and Enting R and Reni M and Thiessen B and Dhermain F and Bromberg JE and Jacob J and Reijneveld JC and Chinot O and Gijtenbeek JMM and Rossiter JP and Balana C and Azevedo ALS and Clement PM and Berghoff A and Tzuk-Shina T and Weller M and Nordal RA and Rees J and Lacombe DA and Mason WP and Stupp R},
  year = {2026},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco-25-02735},
  url = {https://doi.org/10.1200/jco-25-02735}
}

RIS

TY  - JOUR
TI  - Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).
AU  - Baumert BG
AU  - Hegi ME
AU  - van den Bent MJ
AU  - von Deimling A
AU  - Gorlia T
AU  - Hoang-Xuan K
AU  - Brandes AA
AU  - Sargos P
AU  - Taphoorn MJB
AU  - Vauleon E
AU  - Philips C
AU  - Kros JM
AU  - Bady P
AU  - Wick W
AU  - Enting R
AU  - Reni M
AU  - Thiessen B
AU  - Dhermain F
AU  - Bromberg JE
AU  - Jacob J
AU  - Reijneveld JC
AU  - Chinot O
AU  - Gijtenbeek JMM
AU  - Rossiter JP
AU  - Balana C
AU  - Azevedo ALS
AU  - Clement PM
AU  - Berghoff A
AU  - Tzuk-Shina T
AU  - Weller M
AU  - Nordal RA
AU  - Rees J
AU  - Lacombe DA
AU  - Mason WP
AU  - Stupp R
PY  - 2026
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco-25-02735
UR  - https://doi.org/10.1200/jco-25-02735
ER  -

APA

BG, B., ME, H., MJ, V. D. B., A, V. D., T, G., K, H., AA, B., P, S., MJB, T., E, V., C, P., JM, K., P, B., W, W., R, E., M, R., B, T., F, D., JE, B., J, J., JC, R., O, C., JMM, G., JP, R., C, B., ALS, A., PM, C., A, B., T, T., M, W., RA, N., J, R., DA, L., WP, M., & R, S. (2026). Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco-25-02735

Source records

pubmed · retrieved 2026-09-25T17:06:32.695Z
europe-pmc · retrieved 2026-09-25T17:06:32.708Z